Serial cytogenetic studies in allografted patients with chronic myeloid leukemia. 1992

C Bilhou-Nabera, and P Bernard, and G Marit, and F Viard, and M J Gharbi, and Z Wen, and F Lacombe, and A Broustet, and J Reiffers
Laboratoire d'Hématologie, Centre Hospitalier Régional de Bordeaux, France.

Serial marrow karyotyping was performed in 31 chronic myeloid leukemia (CML) patients treated with allogeneic bone marrow transplantation (BMT). Of 11 hematological relapses, seven were heralded for up to 20 months by a cytogenetic relapse (characterized by increasing percentages of Philadelphia (Ph)-positive metaphases, seen on serial karyotypes). Chromosomal abnormalities additional to the Ph, seen before BMT, were not found again at relapse. Relapses were characterized by clonal evolutions of the Ph-positive cells, likely corresponding to cytogenetic patterns of treatment-induced leukemia [del(5q), del(7q), complex karyotypes] and were different from those generally found in CML evolution. Involvement of chromosome 1 was also frequent. Sporadic Ph-positive metaphases (not seen in repeated karyotypes) were seen only during the first 8 months after BMT.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010677 Philadelphia Chromosome An aberrant form of human CHROMOSOME 22 characterized by translocation of the distal end of chromosome 9 from 9q34, to the long arm of chromosome 22 at 22q11. It is present in the bone marrow cells of 80 to 90 per cent of patients with chronic myelocytic leukemia (LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE). Ph1 Chromosome,Ph 1 Chromosome,1 Chromosomes, Ph,Chromosome, Ph 1,Chromosome, Ph1,Chromosome, Philadelphia,Chromosomes, Ph 1,Chromosomes, Ph1,Ph 1 Chromosomes,Ph1 Chromosomes
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D003582 Cytogenetics A subdiscipline of genetics which deals with the cytological and molecular analysis of the CHROMOSOMES, and location of the GENES on chromosomes, and the movements of chromosomes during the CELL CYCLE. Cytogenetic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

C Bilhou-Nabera, and P Bernard, and G Marit, and F Viard, and M J Gharbi, and Z Wen, and F Lacombe, and A Broustet, and J Reiffers
July 1965, Israel journal of medical sciences,
C Bilhou-Nabera, and P Bernard, and G Marit, and F Viard, and M J Gharbi, and Z Wen, and F Lacombe, and A Broustet, and J Reiffers
April 1975, Orvosi hetilap,
C Bilhou-Nabera, and P Bernard, and G Marit, and F Viard, and M J Gharbi, and Z Wen, and F Lacombe, and A Broustet, and J Reiffers
March 1978, The Indian journal of medical research,
C Bilhou-Nabera, and P Bernard, and G Marit, and F Viard, and M J Gharbi, and Z Wen, and F Lacombe, and A Broustet, and J Reiffers
January 1963, Advances in cancer research,
C Bilhou-Nabera, and P Bernard, and G Marit, and F Viard, and M J Gharbi, and Z Wen, and F Lacombe, and A Broustet, and J Reiffers
August 2022, Cancer,
C Bilhou-Nabera, and P Bernard, and G Marit, and F Viard, and M J Gharbi, and Z Wen, and F Lacombe, and A Broustet, and J Reiffers
October 1990, Chinese medical journal,
C Bilhou-Nabera, and P Bernard, and G Marit, and F Viard, and M J Gharbi, and Z Wen, and F Lacombe, and A Broustet, and J Reiffers
October 1989, Cancer genetics and cytogenetics,
C Bilhou-Nabera, and P Bernard, and G Marit, and F Viard, and M J Gharbi, and Z Wen, and F Lacombe, and A Broustet, and J Reiffers
August 1978, The Indian journal of medical research,
C Bilhou-Nabera, and P Bernard, and G Marit, and F Viard, and M J Gharbi, and Z Wen, and F Lacombe, and A Broustet, and J Reiffers
August 2003, Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University,
C Bilhou-Nabera, and P Bernard, and G Marit, and F Viard, and M J Gharbi, and Z Wen, and F Lacombe, and A Broustet, and J Reiffers
August 1966, Pediatrics,
Copied contents to your clipboard!